Talk:Ensitrelvir

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Low	This article has been rated as Low-importance on the project's importance scale.

COVID-19 Mid‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19
Mid	This article has been rated as Mid-importance on the project's importance scale.

Japan: Science & technology Low‑importance

This article is within the scope of WikiProject Japan, a collaborative effort to improve the coverage of Japan-related articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the project, participate in relevant discussions, and see lists of open tasks.JapanWikipedia:WikiProject JapanTemplate:WikiProject JapanJapan-related

Low

This article has been rated as Low-importance on the project's importance scale.

This article is supported by the Science and technology task force.

WikiProject Japan to do list:

Peer review: None
A-class review: None

Featured content candidates –

Articles: None
Pictures: None
Lists: None

Good article nominations: Vinland Saga (TV series), Godzilla Minus One
Add requested images to articles that need them.
Pages for Deletion: Participate in Japan-related deletion discussions.
Improve and expand Japan-related stubs.
Create some requested articles.
Help translate an article from the Japanese Wikipedia into English.
Assess unassessed articles

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ensitrelvir.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

It is requested that a logo be included in this article to improve its quality.
For more information, refer to discussion on this page and/or the listing at Wikipedia:Requested images. The Free Image Search Tool may be able to locate suitable images on Flickr and other web sites.

Upload

USA

https://asia.nikkei.com/Spotlight/Coronavirus/Shionogi-in-talks-with-U.S.-to-supply-COVID-oral-drug 2600:1700:8660:E180:35:9F96:F2C6:2D0F (talk) 05:56, 25 April 2022 (UTC)[reply]

Approved

https://www.shionogi.com/global/en/news/2022/11/e20221122.html

https://www.bloomberg.com/news/articles/2022-11-22/shionogi-s-covid-pill-xocova-wins-japanese-panel-backing 97.35.0.38 (talk) 15:10, 26 November 2022 (UTC)[reply]

china

https://asia.nikkei.com/Business/Pharmaceuticals/Drugmaker-Shionogi-inks-deal-to-market-COVID-pill-in-China 172.87.166.242 (talk) 16:48, 30 December 2022 (UTC)[reply]

https://www.shionogi.com/global/en/news.html

Jun.26, 2023 Seven manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of #Shionogi's COVID-19 oral antiviral ensitrelvir to increase access in low- and middle-income countries.

https://www.shionogi.com/global/en/news/2023/6/20230626-2.html

2023/06/26

Under the terms of the licence agreement, the seven selected generic manufacturers will be able to manufacture and supply ensitrelvir in 117 low- and middle-income countries (LMICs), pending regulatory authorisation or approval in those countries.

At least these countries are mentioned: Ukraine, China, South Africa.

Apr.11, 2023 Shionogi filed for Emergency Use Authorization of Ensitrelvir Fumaric Acid in Taiwan, for the Treatment of COVID-19

Apr.04, 2023 Shionogi Receives U.S. FDA Fast Track Designation for Ensitrelvir Fumaric Acid, an Investigational Oral Antiviral for COVID-19

Jan.04, 2023 New Drug Application of Ensitrelvir Fumaric Acid, a Therapeutic Drug for COVID-19 Accepted for Review in South Korea

91.159.186.9 (talk) 17:14, 29 July 2023 (UTC)[reply]

south korea

https://asia.nikkei.com/Spotlight/Coronavirus/Japan-s-Shionogi-seeks-approval-for-COVID-pill-in-South-Korea 2600:8804:6600:45:78FF:CBD5:85A4:C357 (talk) 01:30, 5 January 2023 (UTC)[reply]

Ensitrelvir (Xocova) and Nirmatrelvir (Paxlovid) are both sars2 main protease inhibitors

It should be mentioned that they have the same mechanism of action.

It is good Paxlovid has a competitor.

https://en.wikipedia.org/wiki/Nirmatrelvir/ritonavir

Other covid-19 drugs have different mechanisms, for example Molnupiravir.

91.159.186.9 (talk) 17:05, 29 July 2023 (UTC)[reply]

The structure is also quite refreshingly new. It looks nothing like a peptide -- well, maybe a tiny bit, but much less compared to Paxlovid. And the way it binds (PDB: 8DZ1) is cool. Might be a good idea to seek out some articles about the design process (doi:10.1021/acsomega.2c03881 looks good). (Holy moly, the article says it also inhibits ExoN and RdRP.) Artoria 2e5 🌉 14:21, 2 October 2023 (UTC)[reply]